Two QOF subscription docs disagree about de-designated tracts
I have a gain coming from a business sale that closes in Q4, so my window runs into 2026, which puts me right on the seam of the transition. I've been through both PPMs twice.
Fund A, $60M target, buys existing multifamily in currently designated tracts and doubles basis to meet substantial improvement. Their risk section says designation status is fixed at the time property is acquired and cites nothing.
Fund B, $110M target, is holding first close until the new designations land January 1, 2027, sitting in treasuries until then. Their docs say the enhanced benefits, including the rural piece from the 2025 law, are only reliably available in the new zones, so acquiring into an expiring tract is an unpriced risk.
Both cannot be right about the same statute. What I'm trying to price is whether Fund A's existing portfolio has an exposure the docs are waving past, and whether Fund B's warehousing of capital blows my 180 day timing since a subscription with no deployment is still a QOF investment on paper only if the fund is actually certified and holding.
Other numbers: Fund A has a 6% pref, 20% over, 1.25% AM fee. Fund B has an 8% pref, 20% over, 2% AM plus a 1% placement fee I did not see until page 74. Fund B also reserves the right to reinvest asset sale proceeds inside the ten year window, which matters a lot to me and Fund A is silent on it.
Where I'm stuck is Fund A's silence on designation risk. Is that ordinary drafting or is that the thing I should walk on?